At HonorHealth, we believe that caring for our patients and the planet goes hand in hand. Recently recognized as one of the “4 best eco-friendly companies to work for inLEARN MORE
In a significant advancement for cardiac care in Arizona, HonorHealth recently became the first non-clinical trial site in the state to successfully perform an FDA-approved minimally invasive tricuspid valve replacement.LEARN MORE
By Suchitra Pilli, MD, MPH, FCCP, DAABIP | HonorHealth Heart Care As the medical community continues to address the long-term impacts of the COVID-19 pandemic, one area of growing importanceLEARN MORE
Breast cancer is a complex disease with various subtypes, each requiring specific treatment approaches. Two of the more aggressive forms are HER2-positive (HER2+) breast cancer, driven by overexpression of theLEARN MORE
First Annual Osteopathic Continuing Medical Education Symposium We are pleased to present this symposium dedicated to advancing osteopathic medicine and healthcare. This symposium brings together experts, practitioners, educators, and enthusiastsLEARN MORE
As part of HonorHealth’s dedicated approach to the comprehensive management of aortic disease, we are excited to announce the formation of the HonorHealth Aortic Program. This program utilizes a multidisciplinaryLEARN MORE
On Tuesday, Nov. 7, 2023, HonorHealth was the first health system in the state to usher in a new era of pacemakers for patients with abnormal or slow heart rhythmsLEARN MORE
Please review HonorHealth’s important update to the preoperative protocol regarding withholding GLP-1 agonist medications for our patients taking them for diabetes or for weight loss, in order to avoid perioperativeLEARN MORE
Atrial fibrillation (Afib) affects over 2.7 million Americans. Until recently, treatment options have been limited. HonorHealth is proud to have an elite cardiovascular program at the forefront of pioneering newLEARN MORE
Physicians at HonorHealth are excited to lead the fight against aggressive brain tumors with two new innovative clinical trials. The GESTALT trial is assessing the role of radioactive brachytherapy implantsLEARN MORE
